Allschwil, CH– Idorsia Ltd. continues its commitment to furthering the science of sleep and insomnia with a symposium and eight poster presentations at World Sleep 2025, a global scientific congress… Read More
New probiotic and prebiotic skincare products offer a natural and effective solution for managing acne-prone skin. Following the partnership announcement with YUN NV, Bausch Health has introduced the YUN ACN… Read More
ALLSCHWIL, CH – Idorsia Ltd. releases an OnDemand investor webcast outlining how TRYVIO™ (aprocitentan) – the first and only hypertension therapy targeting the endothelin pathway – fits into the treatment landscape… Read More
CAMBRIDGE, MA – Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Applications (sBLA) for the 2025-2026 formulas for Spikevax® and mNEXSPIKE®,… Read More
ABCL575 is an Fc-silenced, half-life extended investigational antibody therapy that is being developed for the treatment of atopic dermatitis VANCOUVER, BC – AbCellera (Nasdaq: ABCL) announced it has dosed the… Read More
